Literature DB >> 32453079

68Ga-FAPI PET/CT Detects Gastric Signet-Ring Cell Carcinoma in a Patient Previously Treated for Prostate Cancer.

Yizhen Pang1, Haichao Huang2, Li Fu3, Liang Zhao4, Haojun Chen1.   

Abstract

A 75-year-old man with a history of prostate cancer (T1N0M0, Gleason score 4 + 3) was referred to radionuclide bone scan and Ga-PSMA PET/CT to detect recurrence. Multiple abnormal foci were observed in the axial and appendicular skeleton, which were suggestive of metastatic superscan from prostate cancer. However, histopathological examinations (from bone biopsy) did not support the metastases from prostate cancer. Ga-FAPI PET/CT was then performed to detect the occult tumor, which showed intense activity in the gastric wall. Subsequent gastroscopy examination revealed the diagnosis of GSRCC (gastric signet-ring cell carcinoma). The diagnosis of GSRCC with widespread bone metastases was finally made.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32453079     DOI： 10.1097/RLU.0000000000003099

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  8 in total

1.  [68Ga]Ga-FAPI-04 PET/CT imaging in signet-ring cell carcinoma of sigmoid colon.

Authors:  Lilan Fu; Kongzhen Hu; Ganghua Tang; Hubing Wu; Wenlan Zhou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-04       Impact factor: 9.236

Review 2.  Novel Tracers and Radionuclides in PET Imaging.

Authors:  Christian Mason; Grayson R Gimblet; Suzanne E Lapi; Jason S Lewis
Journal:  Radiol Clin North Am       Date:  2021-09       Impact factor: 1.947

3.  68Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with 18F-FDG PET/CT.

Authors:  Chunxia Qin; Fuqiang Shao; Yongkang Gai; Qingyao Liu; Weiwei Ruan; Fang Liu; Fan Hu; Xiaoli Lan
Journal:  J Nucl Med       Date:  2021-04-16       Impact factor: 11.082

Review 4.  Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review.

Authors:  Paul Windisch; Daniel R Zwahlen; Stefan A Koerber; Frederik L Giesel; Jürgen Debus; Uwe Haberkorn; Sebastian Adeberg
Journal:  Cancers (Basel)       Date:  2020-09-15       Impact factor: 6.639

Review 5.  Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review.

Authors:  Paul Windisch; Daniel R Zwahlen; Frederik L Giesel; Eberhard Scholz; Patrick Lugenbiel; Jürgen Debus; Uwe Haberkorn; Sebastian Adeberg
Journal:  EJNMMI Res       Date:  2021-02-19       Impact factor: 3.138

6.  Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging.

Authors:  Katharina Kessel; Robert Seifert; Matthias Weckesser; Martin Boegemann; Sebastian Huss; Clemens Kratochwil; Uwe Haberkorn; Frederik Giesel; Kambiz Rahbar
Journal:  Ann Nucl Med       Date:  2021-12-02       Impact factor: 2.668

7.  Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study.

Authors:  Donglang Jiang; Xing Chen; Zhiwen You; Hao Wang; Xiaoyun Zhang; Xiuming Li; Shuhua Ren; Qi Huang; Fengchun Hua; Yihui Guan; Jun Zhao; Fang Xie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-23       Impact factor: 9.236

8.  Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond.

Authors:  Chunxia Qin; Yangmeihui Song; Xi Liu; Yongkang Gai; Qingyao Liu; Weiwei Ruan; Fang Liu; Fan Hu; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-09       Impact factor: 10.057
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.